Search

Your search keyword '"pancreas cancer"' showing total 1,432 results

Search Constraints

Start Over You searched for: Descriptor "pancreas cancer" Remove constraint Descriptor: "pancreas cancer"
1,432 results on '"pancreas cancer"'

Search Results

1. An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images.

2. The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma.

3. The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma

4. Data privacy-aware machine learning approach in pancreatic cancer diagnosis

5. Prognostic significance of lymph node metastasis in pancreatic tail cancer: A multicenter retrospective study

6. Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas.

7. Data privacy-aware machine learning approach in pancreatic cancer diagnosis.

8. Venous thromboembolism in patients with pancreatic adenocarcinoma: Disease burden and initiation of ambulatory thromboprophylaxis.

9. Changes in characteristics of gastroenterology center inpatients in Japan because of rapidly aging society.

10. Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis Setting.

11. Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions.

12. Prognostic significance of lymph node metastasis in pancreatic tail cancer: A multicenter retrospective study.

13. Preoperative neutrophil-to-C-reactive protein ratio as a predictor of post-operative complications of pancreas cancer.

14. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.

15. An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images

18. Pancreas Cancer

20. Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when?

21. Evaluation of the availability of single‐position treatment with a rotating gantry and the validity of deformable image registration dose assessment for pancreatic cancer carbon‐ion radiotherapy.

22. Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelines.

23. Naples prognostic score may predict overall survival in metastatic pancreatic cancer.

24. Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells

25. Two-stage pancreaticoduodenectomy: A case report.

26. Neoadjuvant treatment for pancreatic cancer: Controversies and advances

27. Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria.

28. Long noncoding RNAs in pancreas cancer: from biomarkers to therapeutic targets.

29. Evolution of laparoscopic pancreaticoduodenectomy at Westmead Hospital.

30. Changing patterns of care for pancreas cancer in Victoria: the 2022 Pancreas Tumour Summit.

31. Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.

32. Extracellular matrix is the main targeted environment in early stage of pancreatic ductal adenocarcinoma.

33. Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: an international multicenter cohort study.

34. Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma.

35. Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records

36. Obituary: Frank J. Lagerwaard MD, PhD

37. Omics sciences and precision medicine in pancreas cancer.

38. Effect of Covid-19 pandemic on pancreatic cancer surgery.

39. MK2 drives progression of pancreas and colon cancers by suppressing CD8+ T cell cytotoxic function and is a potential immunotherapy target.

40. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.

41. Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment burden.

42. Survival of cancer survivors with a new pancreatic cancer diagnosis

45. Pancreatic metastases to the rectum: a case report and literature review

46. Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system

47. Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [ 18 F]FAPI-74 with [ 18 F]FDG in Patients with PDAC: A Prospective Exploratory Study.

48. Effective anticancer agents based-on two Pillar[5]arene derivatives for pancreas cancer cell lines: synthesis, apoptotic effect, caspase pathway.

50. A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer

Catalog

Books, media, physical & digital resources